- £9.77bn
- £10.43bn
- £2.03bn
- 88
- 12
- 93
- 73
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,338 | 1,318 | 1,525 | 1,853 | 2,034 |
Cost of Revenue | |||||
Gross Profit | 670 | 656 | 767 | 927 | 1,010 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,102 | 1,055 | 1,212 | 1,544 | 1,666 |
Operating Profit | 236 | 263 | 313 | 308 | 368 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 224 | 253 | 304 | 292 | 340 |
Provision for Income Taxes | |||||
Net Income After Taxes | 184 | 203 | 247 | 234 | 269 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 184 | 203 | 244 | 235 | 269 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 184 | 203 | 244 | 235 | 269 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.538 | 0.517 | 0.601 | 0.717 | 0.772 |
Dividends per Share |